Lv1
46 积分 2024-01-13 加入
Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
9小时前
已完结
Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno[2,3-d]pyrimidine-based EGFR inhibitors
1个月前
已完结
Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
1个月前
已完结
FDA approves Merck & Co’s pulmonary arterial hypertension drug sotatercept
4个月前
已完结
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
4个月前
已关闭
Discovery, Synthesis, and Biological Evaluation of Novel Quinoline-Based PDE4 Inhibitors with Potent Anti-Chronic Obstructive Pulmonary Disease Activity
4个月前
已完结
Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia
5个月前
已完结
Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension
6个月前
已完结
Pulmonary hypertension
6个月前
已完结
Pulmonary hypertension
6个月前
已关闭
皖公网安备34019202002308
